KALAMAZOO, Mich., Nov. 9 /PRNewswire-FirstCall/ -- Stryker Corporation announced today that its presentation time at the following investor conference has been revised from the previous announcement dated November 1, 2007.
A simultaneous webcast of the Company’s presentation will be available on Stryker’s website at www.stryker.com via the For Investors page. The presentation for the Piper Jaffray Health Care Conference will be archived for 30 days.
Certain statements made in the presentation may constitute forward-looking statements. They will be based upon management’s current expectations and will be subject to various risks and uncertainties that could cause the Company’s actual results to differ materially from those expressed or implied in such statements. In addition to factors that may be discussed in the presentation, such factors include, but are not limited to: pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company’s products; regulatory actions; unanticipated issues arising in connection with clinical studies and eventual United States Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; changes in economic conditions that adversely affect the level of demand for the Company’s products; changes in foreign exchange markets; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors are contained in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
Stryker Corporation is one of the world’s leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company’s products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; and endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit the company web site at www.stryker.com.
CONTACT: Katherine A. Owen, Stryker Corporation, Vice President, Strategy
and Investor Relations, +1-269-385-2600
Web site: http://www.stryker.com/
